Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin as Add-on to Morphine in Pediatric Chronic Pain
NCT03275012Phase 2Withdrawn
- Start
- Apr 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of gabapentin in neuropathic pain, chronic pain. Planned start Apr 2017; status: withdrawn.
02
Drugs
gabapentin
03
Conditions
neuropathic painchronic pain
Beyond the preview
Go deeper on NCT03275012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03275012.